Development of osteoinductive Si-based coatings to improve dental implants' performance

290 p.

Proposal and validation of methodologies for the categorisation of continuous variables in the development of prediction models

158 p.

Larval development of the spotfin tonguefish (Symphurus oligomerus Mahadeva and Munroe, 1990) (Pleuronectiformes: Cynoglossidae) from the Gulf of California, Mexico

Larval and early juvenile stages of Symphurus oligomerus are described from 24 specimens from the Gulf of California. Meristic features were 48 – 49 total vertebrae, 87–94 dorsal-fin rays, 73–77 anal-fin rays, 12 caudal-fin rays, and five hypural bones. Seven larvae and one juvenile were cleared and stained to obtain the pterygiophore formula (1-3-2-2-2) that confirmed the identification of S. oligomerus. The pigment pattern from preflexion to juvenile stage consists of three bands on the dorsal margin and two bands on the ventral margin formed by star-shaped melanophores on the left side of the body. The intestine in preflexion to postflexion larvae forms an abdominal projection that ends in a short conical appendix. The intestine is supported by three cartilaginous struts; larvae with these physical attributes are called exterilium larvae. Preflexion larvae have two elongated dorsal-fin rays, and in flexion to postflexion larvae the second to the fourth dorsalfin rays are elongate. We found an apparent connection between the size at metamorphosis of the species of Symphurus and the depth distribution range of adults such that the fish species that metamorphose at a larger size have a deeper distribution as adults and exterilium larvae seem to correspond to species that have deeper distributions.

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles

Self-amplifying RNA or RNA replicon is a form of nucleic acid-based vaccine derived from either positive-strand or negative-strand RNA viruses. The gene sequences encoding structural proteins in these RNA viruses are replaced by mRNA encoding antigens of interest as well as by RNA polymerase for replication and transcription. This kind of vaccine has been successfully assayed with many different antigens as vaccines candidates, and has been shown to be potent in several animal species, including mice, nonhuman primates, and humans. A key challenge to realizing the broad potential of self-amplifying vaccines is the need for safe and effective delivery methods. Ideally, an RNA nanocarrier should provide protection from blood nucleases and extended blood circulation, which ultimately would increase the possibility of reaching the target tissue. The delivery system must then be internalized by the target cell and, upon receptor-mediated endocytosis, must be able to escape from the endosomal compartment into the cell cytoplasm, where the RNA machinery is located, while avoiding degradation by lysosomal enzymes. Further, delivery systems for systemic administration ought to be well tolerated upon administration. They should be safe, enabling the multiadministration treatment modalities required for improved clinical outcomes and, from a developmental point of view, production of large batches with reproducible specifications is also desirable. In this review, the concept of self-amplifying RNA vaccines and the most promising lipid-based delivery systems are discussed.